Devyn Smith | BiotechTV

top of page

ASGCT 2026: Arbor Biotechnologies presented in vivo data today showing that they can deliver their RT editor to the CNS with a single AAV capsid

CEO Devyn Smith describes the significance of today's news. Arbor is thinking about numerous CNS conditions, including ALS. Plus, he shares an update on their liver mediated disease programs with partner Chiesi. Coverage brought to you by

Company News

4 hours ago

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page

ASGCT 2026: Arbor Biotechnologies presented in vivo data today showing that they can deliver their RT editor to the CNS with a single AAV capsid

Follow BiotechTV

Sponsors

Sponsor Spotlight